China offers a significant opportunity for biotech companies to accelerate their clinical development. During this brief we will discuss:

• The latest research and trends of biotech clinical trials in China
• How regulatory requirements compare with the US, and what are the benefits for biotechnology companies to involve sites in China
• Feedback from sponsors and investigators